Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00108004

Public ClinicalTrials.gov record NCT00108004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Insulin Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing to achieve the desired level of glycemic control using insulin therapy.

Study identification

NCT ID
NCT00108004
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2003
Primary completion
May 31, 2005
Completion
May 31, 2005
Last update posted
May 20, 2015

2003 – 2005

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
48
Facility City State ZIP Site status
Research Site Anaheim California
Research Site Escondido California
Research Site La Jolla California
Research Site Los Gatos California
Research Site San Francisco California
Research Site Torrance California
Research Site New Britain Connecticut
Research Site Norwalk Connecticut
Research Site Norwich Connecticut
Research Site Washington D.C. District of Columbia
Research Site Clearwater Florida
Research Site Orlando Florida
Research Site Columbus Georgia
Research Site Honolulu Hawaii
Research Site Idaho Falls Idaho
Research Site Indianapolis Indiana
Research Site Vincennes Indiana
Research Site Topeka Kansas
Research Site Wichita Kansas
Research Site Lexington Kentucky
Research Site Baltimore Maryland
Research Site Bloomfield Hills Michigan
Research Site Tupelo Mississippi
Research Site Las Vegas Nevada
Research Site Reno Nevada
Research Site Moorestown New Jersey
Research Site Neptune City New Jersey
Research Site Roseland New Jersey
Research Site New York New York
Research Site Williston Park New York
Research Site Yonkers New York
Research Site Greenville North Carolina
Research Site Lakewood Ohio
Research Site Westlake Ohio
Research Site Portland Oregon
Research Site Philadelphia Pennsylvania
Research Site Wilkes-Barre Pennsylvania
Research Site Charleston South Carolina
Research Site Sumter South Carolina
Research Site Chattanooga Tennessee
Research Site Knoxville Tennessee
Research Site Memphis Tennessee
Research Site Nashville Tennessee
Research Site Arlington Texas
Research Site Dallas Texas
Research Site Olympia Washington
Research Site Madison Wisconsin
Research Site Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00108004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00108004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →